I am thrilled to announce the launch of npj Dementia, for which I will be serving as the Editor-in-Chief. npj Dementia will be fully-open access and publish research that advances the field towards effective disease interventions. (1/3)
It's been a while since I've shared this resource. If you are looking for help wrangling education data in #rstats, this wiki provides code examples organized by common tasks.
https://t.co/DHDjIKAq4M
New data from the @YokoyamaLabUCSF and @UCSFmac is now available on AD Workbench. Researchers can use this dataset to identify novel disease associations, cell-specific impacts, and therapeutic targets for Alzheimer’s.
Access data via AD Workbench: https://t.co/dukUYKPXAD
Very excited for one of the main projects from my first R01 to be published today in @alzdemjournals. Led by @dwsir and @C_WSolsberg, we’ve identified expansion of IFN-driven T cells in patients w/non-familial AD with onset age<65yrs. https://t.co/hR9BizH1Rh 1/3
We are looking for an entry-level SRA who takes pride in contributing to team science through careful work at the bench. The Yokoyama Neurogenetics in Aging Lab at UCSF studies the genetics and immune signatures of neurodegeneration in diverse populations. 1/3
A year in the making, my feature for @SciAm is out today: #LongCOVID Now Looks like a #Neurological Disease, Helping Doctors to Focus Treatments - The causes of long #COVID, which disables millions, may come together in the #brain and nervous system. https://t.co/41yMDvty0C
Join ADDI’s first Researcher Roundtable discussion on Feb 15! Drs. Rhoda Au, Sammy Danso, Vijayalakshmi Ravindranath, and Ms. Kusumadewi Suharya will talk about “The Importance of Diversity in AD Research.” The panel will be moderated by @AlexisOddi.
🚨I wrote about “brain fog”—one of the most common & disabling symptoms of long COVID (and many other pre-pandemic conditions), and one of the most misunderstood.
Here’s what brain fog actually is, and what it’s like to live with it. 1/
https://t.co/Gq8iylgfBr
Want to learn more about clinical heterogeneity in early-onset Alzheimer’s disease? Check out our new review! https://t.co/QldMiOXQ2O 🧠 🧬 @dwsir @relajoie @UCSFmac#Laboyama
Scientists studying the persistent “brain fog” that plagues many after a bout with COVID-19 are reporting, for the first time, abnormalities in the clear liquid surrounding the brain and spinal cord of several patients. https://t.co/JJiRGqy3dq
Some patients who develop #BrainFog after mild #Covid have cerebrospinal-fluid abnormalities, a small UCSF/@WeillCornell study finds. “It’s possible that the immune system...may be functioning in an unintended pathological way," Dr. Joanna Hellmuth says. https://t.co/C4nQcdR7qc
Emotions running high (including tears of relief 🥲) during this exciting surprise moment to remotely celebrate Caroline @SolsbergWarly as she officially becomes a PhD candidate @UCSF@PspgUcsf 😍 We are so proud of you and love having you as part of the #laboyama family! 🥰🦄
Google’s previously internal-only machine learning course by @quaesita represents a true masterclass in putting the fun in fundamentals. Watch here: https://t.co/WPI7ht6vNU